This Year's Sponsors

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Interactive, Technology and Operations services’ all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 674,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities.

Asimov is developing a synthetic biology platform – from cells to software – to enable better design and manufacture of next-generation therapeutics. Asimov’s CHO Edge System for biologic production minimizes the risk of cell line development by enabling exploration of vector design space – Asimov routinely achieve titers of 8–11 g/L across modalities.

Asimov is applying the same approach to improve cell & gene therapies – by developing stable lentiviral cell lines and a best-in-class AAV expression system, and enhancing safety profiles through the creation of synthetic tissue specific promoters.

IDA Ireland was founded in 1949 as the Irish Government agency responsible for the attraction and retention of foreign direct investment (FDI) into Ireland. IDA Ireland partners with multinational companies to attract investment, providing jobs for the economic and social benefit of Ireland.

We have partnered with 1,200 companies to establish operations in Ireland, including all the World’s Top 10 Biopharmaceutical companies.

The biopharmaceutical industry has made a capital investment of approximately $10 billion in new facilities in Ireland, most of which has come in the last 10 years. This represents the biggest wave of investment in new biotech facilities anywhere in the world.

Speak with us and you will soon understand why Ireland has developed Europe’s premier biopharma manufacturing cluster.

Repligen is a bioprocessing-focused life sciences company bringing expertise and innovation to our customers since 1981. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs.

ScaleReady is transforming how cell and gene-modified cell therapies (CGTs) are manufactured. Centered on G-Rex® technology, ScaleReady delivers a lean, high-throughput manufacturing platform that is practical, flexible, scalable, and cost-efficient. CGT entities relying on the breadth and scope of ScaleReady’s expertise can expect to save years of time and millions of dollars on the path to CGT commercialization.

Today, G-Rex is used in ~50% of relevant CGT trials and supports 5 commercially approved therapies, including the industry’s most commercially successful cell therapy. The G-Rex Centric™ Platform is the only manufacturing system capable of meeting patient demand and market scale, giving developers a clear path from process development to profitable commercialization.